Side effects of 5mg tirzepatide: what the dose increase actually feels like

You've just stepped up to 5mg, here's what's likely happening

Picture the scene: it's Tuesday morning, you've administered your first 5mg pen, and by Thursday you feel queasier than you did on the starter dose. That pattern is common. The 2.5mg starting dose exists mainly to let your digestive system adapt to tirzepatide; 5mg is where the medicine's appetite and blood-sugar effects become more pronounced, and your gut knows it.

The most frequently reported tirzepatide 5mg side effects are nausea, loose or more frequent stools, constipation, indigestion and burping, and you can find a detailed breakdown on our dedicated page covering Mounjaro 5mg side effects. Fatigue and mild headaches appear less often. Injection-site redness or itching can occur at any dose. According to the Mounjaro Summary of Product Characteristics on the eMC, gastrointestinal reactions are the most common adverse events across all doses and are typically mild to moderate in severity.

A few practical things help: eating smaller portions, chewing slowly, and avoiding very fatty or rich food on injection day and the day after. Staying well hydrated matters particularly if diarrhoea is the main symptom. Most people find the nausea from the 5mg step-up is at its worst in days three to five and largely gone within a fortnight, though timing varies. If you are finding it hard to eat or keep fluids down, speak to the prescribing team before your next dose rather than pushing through.

Our guide to the 2.5mg to 5mg transition goes into the comparison between the two doses in more detail.

Side effects that need prompt medical attention

For most people, tirzepatide 5mg side effects are manageable inconveniences. A smaller number of people experience symptoms that go beyond that, and it is worth knowing which ones to act on quickly.

On 29 January 2026, the MHRA issued a Drug Safety Update specifically addressing acute pancreatitis with GLP-1 receptor agonist medicines, confirming it as a known but uncommon risk. The symptom to watch for is severe stomach pain, not everyday nausea, but intense, persistent pain that may radiate through to the back, sometimes with vomiting. That warrants same-day emergency assessment; do not wait to see if it passes. The MHRA Drug Safety Update is the reference point for prescribers and patients alike on this.

Other symptoms that need prompt attention: signs of gallbladder trouble (pain in the upper right abdomen, especially after eating), significant dehydration from ongoing vomiting or diarrhoea, any allergic reaction (swelling of the face or throat, difficulty breathing, widespread rash), and (for anyone with diabetes also treated for eye disease) sudden changes in vision. Low mood or thoughts of self-harm should also prompt contact with a healthcare professional without delay.

None of these are reasons to avoid treatment; they are reasons to know the difference between a side effect that settles and one that needs a clinician.

What's different at 5mg compared with other doses

The tirzepatide 5 mg side effect profile sits between the tolerability-focused starter and the higher therapeutic doses. Side effects reported at 7.5mg and above tend to be more frequent simply because the medicine's action is stronger, which is also why the dose escalation schedule exists. If 5mg side effects are still troublesome after two to three weeks, a prescriber might discuss staying at this dose longer before any further increase, or consider whether the current pattern reflects a temporary adjustment or something that needs reviewing.

For comparison, our pages on 2.5mg side effects and 7.5mg tirzepatide side effects cover what changes at each step. The overall Mounjaro side effect picture is summarised on our Mounjaro treatment page.

One group worth noting: women using oral contraceptives should be aware that tirzepatide can slow gastric emptying, which may reduce how reliably the pill is absorbed. NHS guidance recommends adding a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase. This applies at the 5mg step-up just as it did at 2.5mg.

Getting support through the dose increase

Side effects are one of the most common reasons people contact us after starting treatment. Our prescribers are available seven days a week, and if a side effect is affecting your day-to-day life at 5mg, that conversation is exactly what aftercare is there for, not something to save for a scheduled review. You can reach the team through our contact page.

If you are not yet on treatment and are weighing up whether tirzepatide is right for you, the free consultation is the place to start. Our prescribers discuss likely side effects as part of that review, alongside your health history and any medicines you already take. No referral is needed, and the clinical assessment happens the same day. You can read more about what 5mg Mounjaro involves, or explore the treatment options overview if you are still deciding.

Suspected side effects (whether mild or more serious) can also be reported directly to the MHRA via the Yellow Card scheme. Every report contributed to the post-market safety review of tirzepatide, which continues to carry the MHRA's Black Triangle status.